Demographic and Clinical Characteristics of Patients Treated With Lecanemab Stratified by Amyloid-Related Imaging Abnormality Status

Saurabh Rohatgi, Christina M Younan, Rafael E Martinez Imbett, Jeremy N Ford, Matthew Wleklinski, Shenghua Zhu, Javier Romero · 2026

Read Demographic and Clinical Characteristics of Patients Treated With Lecanemab Stratified by Amyloid-Related Imaging Abnormality Status by Saurabh Rohatgi, Christina M Younan, Rafael E Martinez Imbett, Jeremy N Ford, Matthew Wleklinski, Shenghua Zhu, Javier Romero (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13570582.txt.

Description

BackgroundAmyloid-related imaging abnormalities (ARIAs) are among the most important safety considerations during lecanemab treatment for Alzheimer’s disease (AD). Although APOE ε4 carrier status is a recognized ARIA risk factor, the relationship between ARIAs and routine demographic and clinical characteristics in real-world practice remains incompletely characterized.

Catalog record

CREATORSaurabh Rohatgi, Christina M Younan, Rafael E Martinez Imbett, Jeremy N Ford, Matthew Wleklinski, Shenghua Zhu, Javier Romero
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE19 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13570582

Browse the full library · About the Tower of Babel